Assessing health-state utility values in patients with metastatic colorectal cancer: a utility study in the United Kingdom and the Netherlands

被引：0
|
作者：
Dara Stein
F. Joulain
S. Naoshy
U. Iqbal
N. Muszbek
K. A. Payne
D. Ferry
S. H. Goey
机构：
[1] United BioSource Corporation,The Dudley Group NHS Foundation Trust
[2] Sanofi R&D,undefined
[3] Sanofi,undefined
[4] Evidera,undefined
[5] Russells Hall Hospital,undefined
[6] Tweesteden ziekenhuis,undefined
来源：
International Journal of Colorectal Disease | 2014年 / 29卷
关键词：
Colorectal cancer; Oncology; Health-related quality of life; Utilities; Retrospective chart review; EQ-5D;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1203 / 1210
页数：7
相关论文
共 50 条
  • [1] Assessing health-state utility values in patients with metastatic colorectal cancer: a utility study in the United Kingdom and the Netherlands
    Stein, Dara
    Joulain, F.
    Naoshy, S.
    Iqbal, U.
    Muszbek, N.
    Payne, K. A.
    Ferry, D.
    Goey, S. H.
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2014, 29 (10) : 1203 - 1210
  • [2] Health-state utility values in breast cancer
    Peasgood, Tessa
    Ward, Sue E.
    Brazier, John
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2010, 10 (05) : 553 - 566
  • [3] ASSESSING HEALTH-STATE UTILITY VALUES IN AUSTRALIAN PEOPLE WITH MULTIPLE SCLEROSIS
    Ahmad, H.
    van der Mei, I
    Taylor, B.
    Palmer, A. J.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A875 - A875
  • [4] AN ASESSMENT OF HEALTH-STATE UTILITIES IN METASTATIC BREAST CANCER IN THE UNITED KINGDOM
    Nafees, B.
    Patel, C.
    Ray, D.
    Gray, E.
    Lau, H. J.
    Lloyd, A. J.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A157 - A157
  • [5] Assessing health-state utility: is there a uniquely privileged perspective?
    Wasserman, David
    [J]. JOURNAL OF LAW AND THE BIOSCIENCES, 2021, 7 (01):
  • [6] Critical appraisal of health-state utility values used in breast cancer-related cost–utility analyses
    Virginie Nerich
    Sopany Saing
    Eva-Maria Gamper
    Bernhard Holzner
    Xavier Pivot
    Rosalie Viney
    Georg Kemmler
    [J]. Breast Cancer Research and Treatment, 2017, 164 : 527 - 536
  • [7] Validation of the predictive accuracy of health-state utility values based on the Lloyd model for metastatic or recurrent breast cancer in Japan
    Iwatani, Tsuguo
    Inoue, Eisuke
    Tsugawa, Koichiro
    [J]. BMJ OPEN, 2021, 11 (12):
  • [8] Critical appraisal of health-state utility values used in breast cancer-related cost-utility analyses
    Nerich, Virginie
    Saing, Sopany
    Gamper, Eva-Maria
    Holzner, Bernhard
    Pivot, Xavier
    Viney, Rosalie
    Kemmler, Georg
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (03) : 527 - 536
  • [9] QUALITY OF LIFE IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC): A UTILITIES STUDY IN THE UNITED KINGDOM AND THE NETHERLANDS
    Stein, D.
    Joulain, F.
    Iqbal, S. U.
    Naoshy, S.
    Muszbek, N.
    Payne, K. A.
    Ferry, D. R.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A420 - A420
  • [10] HEALTH-STATE UTILITY VALUES IN DIFFUSE LARGE B-CELL LYMPHOMA
    Wang, H.
    Manca, A.
    Crouch, S.
    Bagguley, T.
    Yu, G.
    Aas, E.
    Howell, D.
    Burton, C.
    Patmore, R.
    Roman, E.
    Smith, A.
    [J]. VALUE IN HEALTH, 2018, 21 : S74 - S74
12345